FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2336704975> ?p ?o ?g. }

• W2336704975 abstract "The purpose of our study was to identify a gene expression signature that specifically reflects the tumor suppressive effects of transforming growth factor-β (TGF-β), for use as a negative selective biomarker in clinical trials using TGF-β antagonists. TGF-β effects are highly contextual, and the dogma is that tumor suppressive effects are active in the early stages of carcinogenesis, but that pro-progression effects come to dominate later on. Since TGF-β antagonists are in early phase clinical trials in cancer, it is important to know whether the tumor suppressive effects of TGF-β are still intact in any tumors at the time of diagnosis and treatment, as this would be a contraindication for anti-TGF-β therapy. Existing TGF-β-related gene expression signatures were not designed a priori to discriminate the tumor suppressive from the tumor promoting activities. To address this question, we applied integrated ChIP-chip and transcriptomic approaches in the MCF10A-based model of breast cancer progression. We have previously shown that TGF-β has tumor suppressor activity in the less malignant cell lines of the series (MCF10AT1k, MCF10Ca1h), but that this effect is lost in the most malignant cell line (MCF10Ca1a). Here we showed that the tumor suppressor activity in this model system is specifically dependent on the downstream signaling component Smad3 and not Smad2. Using promoter-wide ChIP-chip, we found that the genomic landscape of TGF-β induced Smad3 binding differed dramatically between the four cell lines, despite their close genetic relatedness and similar Smad3 levels and activation profiles. Interestingly, TGF-β induced Smad3 binding only at loci that were already transcriptionally active, suggesting that TGF-βs may primarily play a modulator rather than an instigator role in regulating transcription. This feature probably contributes importantly to the known contextuality of TGF-β activity. By focusing on the two malignant cell lines (MCF10CA1h and MCF10CA1a), we identified a core signature of 26 TGF-β/Smad3 regulated genes that was specifically associated with the tumor suppressor activity of TGF-β. Unexpectedly, the direction of regulation of 25% of these genes by TGF-β differed in vitro and in vivo, highlighting a further novel contribution to TGF-β contextuality. The in vivo weighted form of the TGF-β/Smad3 tumor suppressor signature (TSTSS) was associated with good outcome specifically in estrogen-receptor positive (ER+) breast cancer patients, suggesting that TGF-β tumor suppressive pathways are still active and influencing disease outcome in a subset of patients at the time of surgery. TGF-β is a potent growth inhibitor for most epithelial cells and the TSTSS was weakly inversely correlated with proliferation in ER+ breast cancer, but the signature prognosticated independently of proliferation in multivariate analysis. Instead, the TSTSS was enriched for genes involved in cellular differentiation and movement, and ephrin was the top enriched signaling pathway. Ephrin knockdown in MCF10Ca1h cells led to increased migration, reduced apoptosis and differentiation and enhanced tumorigenesis. Our demonstration that a subset of breast cancer patients still has an active TGF-β tumor suppressor pathway at the time of surgery has important implications for patient stratification in ongoing clinical trials with TGF-β antagonists. Citation Format: Misako Sato, Mitsutaka Kadota, Binwu Tang, Yu-an Yang, Mengge Shan, Jia Weng, Michael Welsh, Yoshiko Nagano, Aleksandra Michalowski, Howard Yang, Robert Clifford, Maxwell Lee, Lalage Wakefield. Dissecting out the tumor suppressor aspect of TGF-β in breast cancer using integrated genomics. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications; Oct 3-6, 2013; San Diego, CA. Philadelphia (PA): AACR; Mol Cancer Res 2013;11(10 Suppl):Abstract nr B029." @default.
• W2336704975 created "2016-06-24" @default.
• W2336704975 creator A5005160977 @default.
• W2336704975 creator A5005835133 @default.
• W2336704975 creator A5008198753 @default.
• W2336704975 creator A5008522290 @default.
• W2336704975 creator A5015255621 @default.
• W2336704975 creator A5017314515 @default.
• W2336704975 creator A5019702159 @default.
• W2336704975 creator A5028822640 @default.
• W2336704975 creator A5053646631 @default.
• W2336704975 creator A5054154444 @default.
• W2336704975 creator A5059584902 @default.
• W2336704975 creator A5071248345 @default.
• W2336704975 creator A5076336316 @default.
• W2336704975 date "2013-10-01" @default.
• W2336704975 modified "2023-09-26" @default.
• W2336704975 title "Abstract B029: Dissecting out the tumor suppressor aspect of TGF-β in breast cancer using integrated genomics" @default.
• W2336704975 doi "https://doi.org/10.1158/1557-3125.advbc-b029" @default.
• W2336704975 hasPublicationYear "2013" @default.
• W2336704975 type Work @default.
• W2336704975 sameAs 2336704975 @default.
• W2336704975 citedByCount "0" @default.
• W2336704975 crossrefType "proceedings-article" @default.
• W2336704975 hasAuthorship W2336704975A5005160977 @default.
• W2336704975 hasAuthorship W2336704975A5005835133 @default.
• W2336704975 hasAuthorship W2336704975A5008198753 @default.
• W2336704975 hasAuthorship W2336704975A5008522290 @default.
• W2336704975 hasAuthorship W2336704975A5015255621 @default.
• W2336704975 hasAuthorship W2336704975A5017314515 @default.
• W2336704975 hasAuthorship W2336704975A5019702159 @default.
• W2336704975 hasAuthorship W2336704975A5028822640 @default.
• W2336704975 hasAuthorship W2336704975A5053646631 @default.
• W2336704975 hasAuthorship W2336704975A5054154444 @default.
• W2336704975 hasAuthorship W2336704975A5059584902 @default.
• W2336704975 hasAuthorship W2336704975A5071248345 @default.
• W2336704975 hasAuthorship W2336704975A5076336316 @default.
• W2336704975 hasConcept C104317684 @default.
• W2336704975 hasConcept C118131993 @default.
• W2336704975 hasConcept C121608353 @default.
• W2336704975 hasConcept C126322002 @default.
• W2336704975 hasConcept C150194340 @default.
• W2336704975 hasConcept C162317418 @default.
• W2336704975 hasConcept C179185449 @default.
• W2336704975 hasConcept C2778229498 @default.
• W2336704975 hasConcept C2778264664 @default.
• W2336704975 hasConcept C2779256057 @default.
• W2336704975 hasConcept C2781018059 @default.
• W2336704975 hasConcept C2781197716 @default.
• W2336704975 hasConcept C29537977 @default.
• W2336704975 hasConcept C502942594 @default.
• W2336704975 hasConcept C530470458 @default.
• W2336704975 hasConcept C54355233 @default.
• W2336704975 hasConcept C555283112 @default.
• W2336704975 hasConcept C71924100 @default.
• W2336704975 hasConcept C86803240 @default.
• W2336704975 hasConcept C95444343 @default.
• W2336704975 hasConceptScore W2336704975C104317684 @default.
• W2336704975 hasConceptScore W2336704975C118131993 @default.
• W2336704975 hasConceptScore W2336704975C121608353 @default.
• W2336704975 hasConceptScore W2336704975C126322002 @default.
• W2336704975 hasConceptScore W2336704975C150194340 @default.
• W2336704975 hasConceptScore W2336704975C162317418 @default.
• W2336704975 hasConceptScore W2336704975C179185449 @default.
• W2336704975 hasConceptScore W2336704975C2778229498 @default.
• W2336704975 hasConceptScore W2336704975C2778264664 @default.
• W2336704975 hasConceptScore W2336704975C2779256057 @default.
• W2336704975 hasConceptScore W2336704975C2781018059 @default.
• W2336704975 hasConceptScore W2336704975C2781197716 @default.
• W2336704975 hasConceptScore W2336704975C29537977 @default.
• W2336704975 hasConceptScore W2336704975C502942594 @default.
• W2336704975 hasConceptScore W2336704975C530470458 @default.
• W2336704975 hasConceptScore W2336704975C54355233 @default.
• W2336704975 hasConceptScore W2336704975C555283112 @default.
• W2336704975 hasConceptScore W2336704975C71924100 @default.
• W2336704975 hasConceptScore W2336704975C86803240 @default.
• W2336704975 hasConceptScore W2336704975C95444343 @default.
• W2336704975 hasLocation W23367049751 @default.
• W2336704975 hasOpenAccess W2336704975 @default.
• W2336704975 hasPrimaryLocation W23367049751 @default.
• W2336704975 hasRelatedWork W1806549876 @default.
• W2336704975 hasRelatedWork W1983794260 @default.
• W2336704975 hasRelatedWork W2004368752 @default.
• W2336704975 hasRelatedWork W2059402928 @default.
• W2336704975 hasRelatedWork W2099877079 @default.
• W2336704975 hasRelatedWork W2100801124 @default.
• W2336704975 hasRelatedWork W2105363439 @default.
• W2336704975 hasRelatedWork W2113433800 @default.
• W2336704975 hasRelatedWork W2124433932 @default.
• W2336704975 hasRelatedWork W2125397044 @default.
• W2336704975 hasRelatedWork W2284470034 @default.
• W2336704975 hasRelatedWork W2288981300 @default.
• W2336704975 hasRelatedWork W2305886556 @default.
• W2336704975 hasRelatedWork W2334195221 @default.
• W2336704975 hasRelatedWork W2561822658 @default.
• W2336704975 hasRelatedWork W2565238917 @default.
• W2336704975 hasRelatedWork W2688299637 @default.
• W2336704975 hasRelatedWork W2801260573 @default.
• W2336704975 hasRelatedWork W2884317945 @default.
• W2336704975 hasRelatedWork W3197514590 @default.

• next